IntelGenx Technologies Corp. (NASDAQOTH:IGXT)

CAPS Rating: 1 out of 5

Results 1 - 2 of 2

Recs

0
Member Avatar pchop123 (76.64) Submitted: 6/13/2013 12:24:30 PM : Underperform Start Price: $0.53 IGXT Score: -12.12

not very attractive now

Report this Post Reply

Recs

2
Member Avatar Stockhero (< 20) Submitted: 11/16/2011 1:53:20 AM : Outperform Start Price: $0.57 IGXT Score: -26.65

Strong fundamentals here.. One of the cheapest Biotech Stock out there !

1)Very Very low Market cap of $23.5 M
2) Mega drug Pipeline of 9 Products including a potential Blockbuster
3) 2 New NDA filing in 2012
4) NO DEBT
5)Cash till 2014
6) Very strong Institutions and Insider in this stock
7) low float Stock

Intelgenx (IGXT.OB)

Market Cap : $26.1 M
Price: 0.56

IntelGenx Announces FDA Approval of Its High Dose Anti-Depressant CPI-300
http://finance.yahoo.com/news/IntelGenx-Announces-FDA-pz-4172746127.html?x=0&l=1

Company Presentation
http://www.intelgenx.com/_assets/pdf/Intelgenx-Presentation.pdf

Ownership
http://data.cnbc.com/quotes/IGXT.OB/tab/8

interview with ceo
zerbe
http://www.cantechletter.com/2010/12/cantech-letter-interviews-horst-zerbe-president-and-ceo-of-intelgenx/

Article
http://www.biomedreports.com/2011111183312/fda-spproval-is-a-game-changer-for-intelgen

Report this Post 2 Replies
Results 1 - 2 of 2

Featured Broker Partners


Advertisement